Cargando…
Pan-HDAC Inhibitors Promote Tau Aggregation by Increasing the Level of Acetylated Tau
Epigenetic remodeling via histone acetylation has become a popular therapeutic strategy to treat Alzheimer’s disease (AD). In particular, histone deacetylase (HDAC) inhibitors including M344 and SAHA have been elucidated to be new drug candidates for AD, improving cognitive abilities impaired in AD...
Autores principales: | Jeong, Hyeanjeong, Shin, Seulgi, Lee, Jun-Seok, Lee, Soo Hyun, Baik, Ja-Hyun, Lim, Sungsu, Kim, Yun Kyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747090/ https://www.ncbi.nlm.nih.gov/pubmed/31480543 http://dx.doi.org/10.3390/ijms20174283 |
Ejemplares similares
-
Visualization of Tau–Tubulin Interaction in a Living Cell Using Bifluorescence Complementation Technique
por: Shin, Seulgi, et al.
Publicado: (2018) -
Levosimendan inhibits disulfide tau oligomerization and ameliorates tau pathology in Tau(P301L)-BiFC mice
por: Lim, Sungsu, et al.
Publicado: (2023) -
Monitoring of Intracellular Tau Aggregation Regulated by OGA/OGT Inhibitors
por: Lim, Sungsu, et al.
Publicado: (2015) -
Metal Ion Effects on Aβ and Tau Aggregation
por: Kim, Anne Claire, et al.
Publicado: (2018) -
Cell-based Models To Investigate Tau Aggregation
por: Lim, Sungsu, et al.
Publicado: (2014)